Life Technologies' Q2 Revenues Rise 1 Percent; Board Approves $750M Share Buyback Program | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said after the close of the market on Tuesday that revenues in the second quarter increased 1 percent year over year.

The company also said that its board has approved a $750 million share repurchase program on top of the $62 million that remains from its existing repurchase program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.